Article Menu
Need Help?
No Article Versions Notes Found
Cite
Soulières, D.; Greer, W.; Magliocco, A.M.; Huntsman, D.; Young, S.; Tsao, M.-S.; Kamel-Reid, S. KRAS Mutation Testing in the Treatment of Metastatic Colorectal Cancer with Anti-EGFR Therapies. Curr. Oncol. 2010, 17, 31-40. https://doi.org/10.3747/co.v17is1.614
Soulières D, Greer W, Magliocco AM, Huntsman D, Young S, Tsao M-S, Kamel-Reid S. KRAS Mutation Testing in the Treatment of Metastatic Colorectal Cancer with Anti-EGFR Therapies. Current Oncology. 2010; 17(s1):31-40. https://doi.org/10.3747/co.v17is1.614
Chicago/Turabian StyleSoulières, D., W. Greer, Anthony M. Magliocco, D. Huntsman, S. Young, M.-S. Tsao, and Suzanne Kamel-Reid. 2010. "KRAS Mutation Testing in the Treatment of Metastatic Colorectal Cancer with Anti-EGFR Therapies" Current Oncology 17, no. s1: 31-40. https://doi.org/10.3747/co.v17is1.614
APA StyleSoulières, D., Greer, W., Magliocco, A. M., Huntsman, D., Young, S., Tsao, M.-S., & Kamel-Reid, S. (2010). KRAS Mutation Testing in the Treatment of Metastatic Colorectal Cancer with Anti-EGFR Therapies. Current Oncology, 17(s1), 31-40. https://doi.org/10.3747/co.v17is1.614
